$Moderna, Inc.(MRNA)$ This year is providing Moderna with enough cash to fund several pipeline vaccines/therapies to the public marketplace. Now the vaccine is going to become a steady source of income for the foreseeable future. Not only will 2022 be 3 times the income of 2021 but revenue could possibly quadruple in 2023. Add in the fact that old school vaccines cannot change fast enough to cover new variants Moderna will be providing boosters to cover 1/2 the world population. GL LONGS, This is a once in a lifetime opportunity!$Moderna, Inc.(MRNA)$
精彩评论